↓ Skip to main content

Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, November 2018
Altmetric Badge

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective
Published in
ClinicoEconomics and Outcomes Research: CEOR, November 2018
DOI 10.2147/ceor.s180067
Pubmed ID
Authors

Dhvani Shah, Nancy A Risebrough, Johnna Perdrizet, Neeraj N Iyer, Cory Gamble, Tam Dang-Tan

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 17%
Student > Master 8 15%
Student > Bachelor 5 10%
Other 3 6%
Student > Postgraduate 3 6%
Other 7 13%
Unknown 17 33%
Readers by discipline Count As %
Medicine and Dentistry 16 31%
Pharmacology, Toxicology and Pharmaceutical Science 5 10%
Economics, Econometrics and Finance 3 6%
Nursing and Health Professions 2 4%
Psychology 2 4%
Other 5 10%
Unknown 19 37%